Journal
ORGANIC & BIOMOLECULAR CHEMISTRY
Volume 6, Issue 2, Pages 340-348Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/b713407j
Keywords
-
Categories
Ask authors/readers for more resources
A new series of geldanamycin derivatives were synthesized using a semi-synthetic approach involving genetically engineered biosynthetic intermediates. These analogues were then evaluated for anti-proliferation activity in human cancer cell lines, SK-Br3 and SK-Ov3. Most of the synthesized compounds exhibited potent in vitro anti-proliferation activity toward both cell lines. Such compounds potently inhibited the expression of the Hsp90 client protein ErbB2.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available